It’s just business

The painfully high price of Humira is patently wrong | Financial Times

But nearly half of new drugs launched in the US in 2020-21 were priced at more than $150,000 a year, so others have followed its lead. An entire industry has moved towards making products that are breathtakingly expensive.

Please, please, start thinking about reining in IPR.